跳至主要内容
临床试验/JPRN-jRCTs052210098
JPRN-jRCTs052210098
已完成
未知

Safety and efficacy of the stabilizer device using in endovascular therapy for cerebral aneurysm

sakai nobuyuki0 个研究点目标入组 5 人2021年10月4日

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
cerebral aneurysm
发起方
sakai nobuyuki
入组人数
5
状态
已完成
最后更新
2年前

概览

简要总结

Primary endpoint, defined hemorrhagic complication, did not occur because the trial device was stable without unexpected movements. Secondary endpoint for safety, defined 1; ischemic stroke, 2; arterial dissection, 3; vasospasm, did not occur. 4; other adverse event, transient finger fine movement disturbance occurred just after treatment in 1 case, but disappeared spontaneously and no ischemic change on MRI at next day of treatment. This even is not related to device and treatment.

注册库
who.int
开始日期
2021年10月4日
结束日期
2021年12月18日
最后更新
2年前
研究类型
Interventional
性别
All

研究者

发起方
sakai nobuyuki

入排标准

入选标准

  • 1\)Patients who are scheduled to have a flow divertor or coil\-assisted stent for cerebral aneurysm
  • 2\) Patients who are expected to have difficulty delivering the catheter to the treatment site.
  • 3\)Patients aged between 20years and 80years old at the time of concent acquisition
  • 4\)Patients who consented to the study in writing

排除标准

  • 1\)A history of hypersensitivity to nickel or titanium
  • 2\)A patient who is judged by the principal investigator to be inappropriate in this study

结局指标

主要结局

未指定

相似试验